reports
Tilray Brands Reconfirms Strategy to Regain Nasdaq Compliance; Request...
Tilray Brands Reconfirms Strategy to Regain Nasdaq Compliance; Requests Extension to Meet Listing Requirements NEW YORK and LEAMINGTON, Ontario, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle consumer packaged goods company at the forefront of the cannabis, beverage, and wellness industries, today announced that the Company has submitted an application requesting an extension to regain compliance with Nasdaq’s listing standards regarding its price per share. The Company is evaluating several options including...
Tilray Medical stringe una partnership strategica in Italia per render...
Tilray Medical stringe una partnership strategica in Italia per rendere più accessibili gli estratti di cannabis terapeutica FL Group, società di Tilray, collabora con Molteni, una grande azienda farmaceutica che si occupa di terapie del dolore e per il trattamento della dipendenza da sostanze NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Tilray Medical, una divisione di Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY) e leader mondiale nel settore della cannabis terapeutica, impegnata a rafforzare l'alleanza terapeutica tra pazienti e operatori sanitari per consentire decisioni s...
Tilray Medical Forms Strategic Partnership in Italy to Broaden Access ...
Tilray Medical Forms Strategic Partnership in Italy to Broaden Access to Medical Cannabis Extracts Tilray’s FL Group Teams Up with Molteni, a Major Pharmaceutical Firm Focused on Pain and Substance Dependence Therapies NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, announced today that its wholly-owned subsidiary, FL Group S.R.L., has...
Tilray Expands Hemp-Derived Delta-9 THC Beverage Lineup with 10mg Drin...
Tilray Expands Hemp-Derived Delta-9 THC Beverage Lineup with 10mg Drinks from Fizzy Jane’s and Happy Flower Brands NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) -- . (“Tilray”) (NASDAQ: TLRY and TSX: TLRY) is building on the momentum of its hemp-derived Delta-9 THC (HDD9) beverage portfolio with new 10mg format extensions from its brands: and . Fizzy Jane’s, the sparkling seltzer line that debuted this spring in Georgia, North Carolina, and South Carolina, is now available in a 10mg HDD9 THC format, enhancing the buzz while keeping the same crisp, fruit-forward refreshment fans love. With 15...
Tilray Brands Launches The Humble Seed Whole Wheat Protein Crackers at...
Tilray Brands Launches The Humble Seed Whole Wheat Protein Crackers at Whole Foods Market The Humble Seed Introduces the Ultimate Protein Snack and Better-for-You Crackers with 5g of Superseed Protein NEW YORK and WINNIPEG, Manitoba, Aug. 07, 2025 (GLOBE NEWSWIRE) -- The Humble Seed, a better-for-you snack brand from Tilray Wellness a subsidiary of Tilray Brands, Inc. (“Tilray”) (NASDAQ: TLRY; TSX: TLRY), today announced the launch of its new featuring 5g of plant-based protein per serving. Available in three crave-worthy flavors—Sea Salt, Garlic Herb, and Rosemary Sea Salt—this innova...
InspireMD Reports Second Quarter 2025 Financial Results
InspireMD Reports Second Quarter 2025 Financial Results --- Management to host investor conference call today, August 5th, at 8:30am ET --- MIAMI, Aug. 05, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced financial and operating results for the second quarter and six months ended June 30, 2025. Recent Business Highlights: Received premarket application (PMA) approval from the U.S. Food and Drug Administration (FDA) for the CGuard Prime carotid stent systemCommenced commercial lau...
- Jonathan Moreland
ANTM ANTHEM INC.
SSB SOUTH STATE CORPORATION
SNV SYNOVUS FINANCIAL CORP.
SIGI SELECTIVE INSURANCE GROUP INC.
SFNC SIMMONS FIRST NATIONAL CORPORATION CLASS A
RLI RLI CORP.
PSX PHILLIPS 66
PRGS PROGRESS SOFTWARE CORPORATION
PNFP PINNACLE FINANCIAL PARTNERS INC.
NVCR NOVOCURE LTD.
MTH MERITAGE HOMES CORPORATION
MSCI MSCI INC. CLASS A
MOFG MIDWESTONE FINANCIAL GROUP
FBIZ FIRST BUSINESS FINANCIAL SERVICES
CNC CENTENE CORPORATION
CHTR CHARTER COMMUNICATIONS INC. CLASS A
ALGN ALIGN TECHNOLOGY INC.
UPS UNITED PARCEL SERVICE INC. CLASS B
PETS PETMED EXPRESS INC.
EPD ENTERPRISE PRODUCTS PARTNERS L.P.
PBT PERMIAN BASIN ROYALTY TRUST
LIND LINDBLAD EXPEDITIONS HOLDINGS
KYN KAYNE ANDERSON MLP INVESTMENT CO.
PLBC PLUMAS BANCORP
CZWI CITIZENS COMMUNITY BANCORP
MBIN MERCHANTS BANCORP
PGC PEAPACK-GLADSTONE FINANCIAL CORP.
LOOP LOOP INDUSTRIES
CHMG CHEMUNG FINANCIAL CORP.
FVCB FVCBANKCORP
TLRY TILRAY
TROX TRONOX HOLDINGS PLC
AMTB AMERANT BANCORP (A)
PCB PACIFIC CITY FINANCIAL CORP
DMAC DIAMEDICA THERAPEUTICS INC.
CRDF CARDIFF ONCOLOGY INC
ABSI ABSCI CORP
NSPR INSPIREMD INC
BRCC BRC INC
JMSB JOHN MARSHALL BANCORP INC
PRME PRIME MEDICINE INC
MMC MARSH & MCLENNAN COMPANIES INC.
STRW STRAWBERRY FIELDS REIT INC.
AURX NUO THERAPEUTICS
DMA INC.
MRAI DESTRA MULTI ALTERNATIVE FUND
GF MARPAI
CVM INC.
THE NEW GERMANY FUND
INC.
CEL-SCI CORPORATION
InspireMD Announces the Appointment of Raymond W. Cohen to its Board o...
InspireMD Announces the Appointment of Raymond W. Cohen to its Board of Directors MIAMI, July 31, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced the appointment of Raymond W. Cohen to its Board of Directors. Mr. Cohen has over 40 years of leadership experience in medical technology with a successful track record of scaling commercial operations and creating shareholder value through market leadership and successful exit transactions. “We are thril...
InspireMD Announces Combined Financings of $58 Million
InspireMD Announces Combined Financings of $58 Million Proceeds Bolster Balance Sheet to Commercialize Recently FDA Approved Best-In-Class Carotid Stent MIAMI, July 31, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced the Company has raised approximately $58 million in combined gross proceeds through an equity private placement (“PIPE”) financing and the exercise of warrants that were triggered by the Company’s premarket application approval (“PMA”) of...
- Jonathan Moreland
Tilray Brands Reports Fourth Quarter and Fiscal 2025 Financial Results
Tilray Brands Reports Fourth Quarter and Fiscal 2025 Financial Results Fiscal Year Net Revenue of $821 Million, $834 Million in Constant Currency, Strategic Decisions Impacted Revenue by $35 Million Q4 Consolidated Adjusted EBITDA is the 2nd Highest in the Company’s History International Cannabis Revenue Increased 71% in Q4 and 19% for the Fiscal Year; Canadian Cannabis Remained #1 by Revenue in the Fiscal Year; Global Cannabis Gross Margin Increased by ~700 Basis Points in the Fiscal Year 19% Revenue Growth in Tilray Beverages with $241 Million for the Fiscal Year 9% Revenue Growth in ...
Award-Winning Breckenridge Distillery Makes Bold Entry into Tequila wi...
Award-Winning Breckenridge Distillery Makes Bold Entry into Tequila with Launch of Casa Breck Breckenridge Distillery Unveils Casa Breck: An Artisanal Tequila inspired by the rich traditions of Jalisco and the adventurous spirit of the Rockies BRECKENRIDGE, Colo., July 24, 2025 (GLOBE NEWSWIRE) -- , an award-winning craft distillery and spirits brand by Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), proudly celebrates International Tequila Day with the launch of - a bold leap into a new spirits category. Crafted with reverence for tradition and inspired by cross-cultural storytellin...
InspireMD to Announce Second Quarter 2025 Financial Results
InspireMD to Announce Second Quarter 2025 Financial Results MIAMI, Fla., July 22, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that it will release its second quarter 2025 financial results on Tuesday, August 5, 2025. In conjunction with the release, InspireMD will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss its financial results and recent highlights. Interested parties may access the live earnings call via telephone by dialing 1-800-579-2543 for ...
Breckenridge Distillery Launches Mock One: Bold, Premium Non-Alcoholic...
Breckenridge Distillery Launches Mock One: Bold, Premium Non-Alcoholic Alternatives to Whiskey, Tequila, Gin & Rum - Crafted for Everyone Who Loves a Great Drink BRECKENRIDGE, Colo., July 17, 2025 (GLOBE NEWSWIRE) -- , an award-winning craft distillery and spirits brand by Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), is pleased to announce the launch of , a new line of non-alcoholic spirits. Mock One is not just another non-alcoholic spirit - it’s crafted by the team behind one of the most awarded craft distilleries in the United States. Backed by the expertise of the renowned Brecke...
Tilray Brands to Announce Fourth Quarter and Fiscal Year 2025 Financia...
Tilray Brands to Announce Fourth Quarter and Fiscal Year 2025 Financial Results on July 28, 2025 NEW YORK and LEAMINGTON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, today announced that the Company will release its financial results for the fourth quarter and full fiscal year ended May 31, 2025, after market close on Monday, July 28, 2025. Live Conference Call and Audio Webcast Tilray will ho...
InspireMD Announces U.S. Commercial Launch of CGuard® Prime Carotid St...
InspireMD Announces U.S. Commercial Launch of CGuard® Prime Carotid Stent System for the Prevention of Stroke MIAMI, July 09, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard Prime carotid stent system for the prevention of stroke, today announced the official commercial launch of the CGuard Prime carotid stent system in the U.S., following its premarket application (PMA) approval from the U.S. Food and Drug Administration (FDA). The CGuard Prime was engineered specifically to minimize both early and late embolism risk by effectively trapping potential emb...
Beers, Live Music, Hot Dogs and Fireworks: Everything You Need for an ...
Beers, Live Music, Hot Dogs and Fireworks: Everything You Need for an Epic 4th Of July Celebration Tilray Brands Announces Independence Day Parties Across the U.S. NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company, is excited to share that its craft beer taprooms across the U.S. are rolling out a stellar lineup of events to make this 4th of July unforgettable. From live music and limited-release brews to barbecues and Independence Day festivities, each taproom is set to bring its o...
Breckenridge Distillery Unveils Limited-Edition Collectors Art Series ...
Breckenridge Distillery Unveils Limited-Edition Collectors Art Series Collaboration with Renowned Artist Miles Toland For Its Fifth Annual Collectors Art Series, Breckenridge Distillery Partners with Visionary Artist to Create Label for Its New Calvados Cask Release BRECKENRIDGE, Colo., July 01, 2025 (GLOBE NEWSWIRE) -- , one of the most-awarded craft distilleries in the U.S., and a craft spirits brand by Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), proudly announces the fifth edition of its acclaimed . This year, the distillery partnered with muralist and painter Miles Toland to c...
Tilray Medical veröffentlicht bahnbrechende Forschungsergebnisse zur P...
Tilray Medical veröffentlicht bahnbrechende Forschungsergebnisse zur Pharmakokinetik von THC- und CBD-Formulierungen Neue Studie liefert Erkenntnisse über die Bioverfügbarkeit von medizinischen Cannabisformulierungen für therapeutische Behandlungen NEW YORK, June 27, 2025 (GLOBE NEWSWIRE) -- Tilray Medical, ein Geschäftsbereich von Tilray Brands, Inc. („Tilray” oder das „Unternehmen”) (Nasdaq: TLRY; TSX: TLRY) und ein weltweit führender Anbieter von medizinischem Cannabis, der die therapeutische Allianz zwischen Patienten und Ärzten stärkt, um fundierte, individuelle Gesundheitsentschei...
Tilray Medical publie une recherche pionnière sur la pharmacocinétique...
Tilray Medical publie une recherche pionnière sur la pharmacocinétique des formulations de THC et de CBD La nouvelle étude fournit des informations sur la biodisponibilité des formulations de cannabis thérapeutique à des fins thérapeutiques NEW YORK, 27 juin 2025 (GLOBE NEWSWIRE) -- Tilray Medical, une division de Tilray Brands, Inc. (« Tilray » ou la « Société ») (Nasdaq : TLRY ; TSX : TLRY) et leader mondial du cannabis thérapeutique, qui favorise l’alliance thérapeutique entre les patients et les professionnels de santé afin de leur permettre de prendre des décisions éclairées et per...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.